ArticleMolecular cancer therapeutics2022

Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer.

Alan P Lombard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.